Trial Profile
Clinical Trials Insight: 700030198
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2008
Price :
$35
*
At a glance
- Drugs Fosalvudine tidoxil (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics; Therapeutic Use
- 30 Jan 2008 New trial record.
- 12 Nov 2007 Results are expected in the first quarter of 2008.